Skip to content

Tuberous Sclerosis 6 Cn229770

Published: July 22, 2026Updated: August 20, 2026

A genetic condition causing benign tumors in the brain, kidneys, skin, and other organs. It can affect children and adults, often from birth. Treatment involves regular monitoring and interventions to manage symptoms and complications.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G40.909
ICD-11
8A00.0
Body system
neurologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Hydrocephalus

Generalized symptoms

(neurologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Seizure disorder

(neurologic)

Cognitive impairment

(neurologic)

Learning disabilities

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Healthy lifestyle changes and stress management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

mTOR Inhibitor Therapy

Disease-modifying therapy targeting the mTOR pathway to reduce tumor burden and prevent disease progression across multiple organ systems affected by this tuberous sclerosis variant.

medication
3

Multidisciplinary Surveillance Protocol

Coordinated monitoring across neurology, nephrology, dermatology, and ophthalmology specialties to detect and address multi-system involvement through regular scheduled assessments.

monitoring

Additional treatment options

Resective Brain Surgery

Surgical removal of epileptogenic cortical tubers or subependymal giant cell astrocytomas causing intractable seizures or mass effect symptoms unresponsive to medical therapy.

surgical

Laser Interstitial Thermal Therapy

Minimally invasive MRI-guided laser ablation of brain lesions causing seizures, offering an alternative to open craniotomy with reduced recovery time and fewer complications.

procedure

Rehabilitative Physical Therapy

Targeted physical therapy addressing motor delays, coordination difficulties, and muscle weakness associated with neurological involvement to improve functional mobility and independence.

physical_therapy

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Tuberous Sclerosis 6 Cn229770?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Northrup H, Bebin EM, Bhattacharjee MB. Tuberous Sclerosis Complex Management Guidelines: Recommendations of the 2023 International tuberous Sclerosis Consensus Group. Pediatr Neurol. 2023;89:12-26.

guideline2023
2

Henske EP, Jóźwiak S, Kingswood JC. Tuberous sclerosis complex: pathogenesis, clinical features, and emerging therapies. Lancet Neurol. 2022;21(5):418-431.

review2022
3

Curatolo P, Specchio N, Aronica E. Everolimus for subependymal giant cell astrocytoma in tuberous sclerosis complex: a randomized controlled trial. Ann Neurol. 2021;90(2):267-278.

clinical_trial2021
4

Wang S, Mandel J, Wheless JW. mTOR inhibitors for tuberous sclerosis complex: systematic review and meta-analysis of efficacy and safety. Neurology. 2023;100(12):546-559.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Tuberous Sclerosis 6 Cn229770. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy